RUNX1 has been associated with anti-cancer therapy resistance through PI3-kinase/Akt pathways in Acute megakaryoblastic leukemia (AMKL) individuals without Down syndrome (non-DS-AMKL)107. The gene discussed is RUNX1; the disease is Down syndrome.